CORPORACION DEL CENTRO CARDIOVASCULA — History
CCN 400124 | 3-year financial timeline | COVID resilience: 62/100
🛡️ Public data only — no PHI permitted on this instance.
$77M
Latest Revenue (FY2022)
+8.9%
Revenue CAGR (3yr)
-14.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $65M | $71M | $77M | +8.8% | +8.9% |
| Operating Expenses | $74M | $77M | $88M | +15.0% | +8.8% |
| Operating Margin | -14.5% | -8.0% | -14.2% | -77.6% | +0.0% |
| Net Income | $-9M | $-6M | $-11M | -93.2% | +0.0% |
| Licensed Beds | 164 | 155 | 164 | +5.8% | +0.0% |
| Total Patient Days | 22,432 | 24,498 | 24,492 | -0.0% | +4.5% |
| Medicare Day % | 10% | 7% | 9% | +24.5% | -7.2% |
| Medicaid Day % | 22% | 24% | 21% | -12.3% | -2.6% |
COVID Impact & Recovery
Resilience Score: 62/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +18.7% ($65M → $77M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.9%
This Hospital
+7.6%
State Avg
Latest Margin
-14.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $83M | -14.1% |
| FY2024 (proj) | $89M | -14.0% |
| FY2025 (proj) | $95M | -13.9% |